Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The IASLC 2022 World Conference on Lung Cancer congress held in Vienna, Austria gathered clinicians, researchers and scientists in the field of lung cancer and thoracic oncology from around the globe to discuss the latest exciting updates in lung cancer.
🎥We had the pleasure of catching up with @AdamJanuszewski this morning to discuss the BTOG Therapeutics Symposium, ADCs in #lungcancer, and more at #BTOG24
🎥@Debj_p of @ORNL explores targeted radionuclide therapy, utilizing actinium-225 for precise cancer treatment. Promising results in nanoparticle-mediated delivery show potential for personalized oncology:
The IASLC 2022 World Conference on Lung Cancer congress held in Vienna, Austria gathered clinicians, researchers and scientists in the field of lung cancer and thoracic oncology from around the globe to discuss the latest exciting updates in lung cancer.
🎥We had the pleasure of catching up with @AdamJanuszewski this morning to discuss the BTOG Therapeutics Symposium, ADCs in #lungcancer, and more at #BTOG24
🎥@Debj_p of @ORNL explores targeted radionuclide therapy, utilizing actinium-225 for precise cancer treatment. Promising results in nanoparticle-mediated delivery show potential for personalized oncology:
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.